'Brilliant concept' for Avastin fades

Links shared publicly online about this topic.

483
total visits

'Brilliant concept' for Avastin fades

Avastin has largely lived up to its billing as an innovative way to attack tumors, along the way generating the most revenue for any cancer drug while being Roche Holding AG's best-selling treatment with $6.88 billion...

View full resource at sfgate.com

Tags: Cancer, Cancer Medication, Colorectal Cancer Medication, Drug, Pharma, Avastin

Most Recently Shared on February 24, 2011 at 4:25 pm By:

Marya Zilberberg, MD

RT @RitaRubin: Waning enthusiasm about Avastin: http://bit.ly/fVzteh #breastcancer #pharma

1 year ago...

Retweet

Favorite

Also Shared By:

RitaRubin

Avastin - Roche's 'Brilliant Concept' Fades Amid Doctor Disappointment - Bloomberg - Jack's posterous

pharmagossip.posterous.com — “Avastin - Roche's 'Brilliant Concept' Fades Amid Doctor Disappointment - Bloomberg - Jack's posterous” View full resource at pharmagossip.posterous.com